Details for 2012840074

Up to date per 01.04.2026

Actions

Title / Product Name

CD40L-SPECIFISCHE TN3-DERIVIERTE GERÜSTE UND VERFAHREN ZU IHRER VERWENDUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012840074

EP Publication Number

2771022

E-Number

1285513

Language

PCT Number

US12059477

Publication Date

03.09.2014 A

01.07.2020 B1

Registration Date

01.07.2020

AT Publication Date

15.07.2020

Application Date

10.10.2012

Registration Number

Priorities

11.10.2011

201161546028 P

IPC

A61K 38/05 20060101AFI20150629BHEP

Maximum Duration of Protection

10.10.2032

Owner

Viela Bio, Inc.One Medlmmune Way Gaithersburg, MD 20878US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

COYLE, Anthony12 Union Park Boston, MA 02118US

BACA, Manuelc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

THISTED, Thomasc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

DRABIC, Staceyc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

GRINBERG, Lubac/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

NOVARRA, Shabazzc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

OGANESYAN, Vahehc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

HERBST, Ronaldc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

SPENCER, David, Kennethc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

Information about Fees